Design Therapeutics, Inc. DSGN Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s interest income?
- Design Therapeutics, Inc. (DSGN) reported interest income of $2.07M in Q1 2026.
- How has Design Therapeutics, Inc.'s interest income changed year-over-year?
- Design Therapeutics, Inc.'s interest income decreased by 23.4% year-over-year, from $2.7M to $2.07M.
- What is the long-term trend for Design Therapeutics, Inc.'s interest income?
- Over 2 years (2023 to 2025), Design Therapeutics, Inc.'s interest income has grown at a -7.6% compound annual growth rate (CAGR), from $11.33M to $9.68M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.